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Deﬁning the Contribution of MC1R Physiological
Ligands to ATR Phosphorylation at Ser435, a
Predictor of DNA Repair in Melanocytes
Stuart G. Jarrett1, Erin M. Wolf Horrell1,2, Mary C. Boulanger3 and John A. D’Orazio1,2,4,5,6
The melanocortin 1 receptor (MC1R), a GS-coupled receptor that signals through cAMP and protein kinase A
(PKA), regulates pigmentation, adaptive tanning, and melanoma resistance. MC1R-cAMP signaling promotes
PKA-mediated phosphorylation of ataxia telangiectasia and rad3-related (ATR) at Ser435 (ATR-pS435), a
modiﬁcation that enhances nucleotide excision repair (NER) by facilitating recruitment of the XPA protein to
sites of UV-induced DNA damage. High-throughput methods were developed to quantify ATR-pS435, measure
XPA-photodamage interactions, and assess NER function. We report that melanocyte-stimulating hormone
(α-MSH) or ACTH induce ATR-pS435, enhance XPA’s association with UV-damaged DNA and optimize
melanocytic NER. In contrast, MC1R antagonists agouti signaling protein (ASIP) or human β-defensin 3 (HBD3)
interfere with ATR-pS435 generation, impair the XPA–DNA interaction, and reduce DNA repair. Although ASIP
and HBD3 each blocked α-MSH-mediated induction of the signaling pathway, only ASIP depleted basal
ATR-pS435. Our ﬁndings conﬁrm that ASIP diminishes agonist-independent MC1R basal signaling whereas HBD3
is a neutral MC1R antagonist that blocks activation by melanocortins. Furthermore, our data suggest that
ATR-pS435 may be a useful biomarker for the DNA repair-deﬁcient MC1R phenotype.
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INTRODUCTION
The melanocortin 1 receptor (MC1R) is critical to melanocyte
physiology, inﬂuencing resistance to malignant degeneration
(Valverde et al., 1996), pigmentation (Valverde et al., 1995),
the adaptive tanning response (D'Orazio et al., 2006), and UV
resistance (Hauser et al., 2006). MC1R is a Gs-coupled
receptor that signals through cAMP and protein kinase A
(PKA)-mediated mechanisms when activated by ACTH or
α-melanocyte stimulating hormone (α-MSH). Engagement of
MC1R with agonistic ligands induces a number of pro-
differentiation pathways, including upregulation of melanin
synthesis and production of brown/black eumelanin instead
of red/yellow pheomelanin (Abdel-Malek et al., 2000, 2014).
MC1R signaling is impacted by a variety of ligands, which
together regulate MC1R-cAMP responses. The agouti signal-
ing protein (ASIP) functions as an inverse agonist for MC1R
decreasing MC1R basal signaling (Suzuki et al., 1997), while
human β-defensin 3 (HBD3) functions as a neutral antagonist
blunting the effects of other MC1R ligands (Candille et al.,
2007; Nix et al., 2013). In humans, MC1R is highly
polymorphic with more than 70 variants, a few of which
blunt MC1R-cAMP signaling responses (Garcia-Borron et al.,
2014). At least ﬁve “red hair color” (RHC) single-nucleotide
polymorphisms (MC1R-D84E, -R142H, -R151C, -R160W,
and -D294H) are associated with red hair, freckling, fair skin,
and UV sensitivity (Valverde et al., 1995).
Though MC1R loss is clearly linked with defective basal
and adaptive pigmentation (D'Orazio et al., 2006), MC1R
signaling also protects melanocytes against carcinogenesis
independent of pigmentation. Most notably, cAMP facilitates
the repair of UV-induced damage via enhancing nucleotide
excision repair (NER) (Hauser et al., 2006; Kadekaro et al.,
2010). The importance of NER for resistance to melanoma
and other UV-induced cancers is evident by the natural
history of XP patients who, because of homozygous loss of
any of eight essential NER proteins, have more than a three-
log higher risk of melanoma and keratinocyte malignancies
(DiGiovanna and Kraemer, 2012). XPA is part of the core
incision complex of NER and interacts with DNA along with
other NER and damage response proteins (Kang et al., 2011).
Similarly, ATR is critical to UV DNA damage signaling
(Matsuoka et al., 2007) and is linked with NER (Lindsey-Boltz
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et al., 2009). Recently we described a molecular link between
α-MSH-MC1R signaling and the NER pathway involving both
ATR and XPA (Jarrett et al., 2014). Speciﬁcally, MC1R-cAMP
signaling increased NER through PKA-mediated phosphoryla-
tion of ATR at S435 (ATR-pS435), which promoted ATR’s
interaction with XPA to accelerate recruitment of the
ATR-XPA complex to sites of photodamage. In this report, we
examine how agonistic and antagonistic ligands of MC1R affect
ATR-pS435 generation, XPA-DNA interactions, and NER
efﬁciency. To accomplish this, two high-throughput ﬂuores-
cence assays were developed. Using biotinylated peptides
mimicking the primary sequence of ATR surrounding S435, we
measured endogenous ATR phosphorylation following agonism/
antagonism of MC1R. In addition, using a biotinylated synthetic
construct utilized in the oligonucleotide retrieval assay (ORA)
(Shen et al., 2014), we studied the effect of MC1R agonism/
antagonism on XPA or ATR’s interactions with photolesion-
containing DNA as well as functional effects on NER efﬁciency.
We found that physiological ligands of MC1R regulate levels of
ATR-pS435, XPA-photodamage association, and NER activity.
Antagonizing MC1R with either ASIP or HBD3 abolished
ATR-pS435 production, impaired XPA–DNA associations, and
reduced NER efﬁciency. ASIP but not HBD3 downregulated
basal levels of ATR-pS435 and NER capacity. Taken together,
our study suggests that ATR-pS435 may be a useful biomarker
for the DNA repair-deﬁcient MC1R phenotype and introduces
two sensitive assays that enable quantiﬁcation of ATR-pS435
and protein interactions with UV-damaged DNA.
RESULTS
ATR phosphorylation at S435 is a biomarker for MC1R function
cAMP-mediated enhancement of NER is dependent on
phosphorylation of ATR on the S435 residue by PKA (Jarrett
et al., 2014). To evaluate whether phosphorylation of ATR can
be used as a marker of MC1R function, we compared the
ability of primary human melanocytes (PHMs), melanoma
cells, and HEK cells transfected with wild-type MC1R or
mutant RHC variants (R160W and D294H; Supplementary
Figure 1 online) to respond to α-MSH. A high-throughput
ﬂuorescence-based screening method was developed using a
biotinylated peptide containing ATR-S435 and a phospho-
speciﬁc anti-ATR-pS435 antibody. All lines expressing wild-
type MC1R demonstrated dose-dependent increases in S435
phosphorylation when incubated with α-MSH or forskolin, a
direct activator of adenylate cyclase (Figure 1a–c). Phosphor-
ylation of ATR at S435 closely correlated with cAMP
generation (Supplementary Figure 2 online). In contrast,
MC1R mutant cells failed to generate ATR-pS435 (Figure 1d–
f) and had blunted cAMP generation (Supplementary Figure 2
online) after α-MSH exposure, but showed robust responses to
forskolin. Enzyme kinetics for PKA-mediated ATR phosphor-
ylation were calculated across increasing peptide concentra-
tions (Figure 2) and incubation times (Figure 3). α-MSH
induced effective ATR-pS435 generation in cells expressing
wild-type MC1R (Figure 2a–c and Supplementary Table 1
online). In contrast α-MSH yielded no measureable ATR
phosphorylation in cells bearing MC1R-RHC (Figure 2d–f and
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Figure 1. ATR phosphorylation at S435 is a biomarker of MC1R-cAMP signaling. Cell lysates were extracted from (a) HEK293-MC1R-WT, (b) PHM-MC1R-WT,
(c) SK-MEL2-MC1R-WT, (d) HEK293-MC1R-R160W, (e) HEK293-MC1R-D294H, and (f) A375-MC1R-R151C 30minutes after treatment with indicated
concentrations of forskolin, α-MSH or vehicle. Wild-type and mutant MC1R expression in HEK293 cells was conﬁrmed via western blotting (Supplementary
Figure 1 online). ATR-pS435 was measured using 10 μM CPKRRRLSSSLNPS as a substrate with anti-ATR-pS435 antibody coupled with ﬂuorescence detection.
Note that while forskolin promoted generation of ATR-pS435 across cell types, α-MSH did so only when MC1R was functional. ATR, ataxia telangiectasia and
rad3-related; MC1R, melanocortin 1 receptor; MSH, melanocyte-stimulating hormone; PHM, primary human melanocyte; RFU, relative ﬂuorescence unit.
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Supplementary Table 1 online). Pharmacologic cAMP induc-
tion by forskolin rescued ATR-pS435 generation in each line
irrespective of MC1R status and even surpassed the efﬁciency of
α-MSH-MC1R signaling in MC1R-WT cells. Forskolin-induced
generation of ATR-pS435 in PHMs occurred concomitantly with
cAMP generation, CREB phosphorylation, and tyrosinase
expression (Supplementary Figure 3 online). A linear relationship
between ATR-pS435 generation and amount of nuclear extract
was conﬁrmed (Supplementary Figure 4 online). Pre-immune
rabbit serum did not recognize the peptide regardless of
phosphorylation status, anti-pS435 ATR did not recognize a
non-phosphorylatable (S435A) peptide, and total-ATR recog-
nized the peptide regardless of phosphostatus of S435
(Supplementary Figure 5 online).
To characterize the kinetics of PKA-mediated S435
phosphorylation, we tested the ability of PKA to directly
phosphorylate ATR-S435 in a cell-free system using recombi-
nant catalytically-active PKA. We noted dose- and time-
dependent phosphorylation of the ATR S435 peptide
(Figure 3a) but not the ATR A435 mutant peptide incapable
of being PKA phosphorylated (Figure 3b). Addition of the PKA
inhibitors H-89 or PKI abolished phosphorylation of S435
(Figure 3a), conﬁrming the need for functional PKA activity.
Enzyme kinetic studies demonstrated dose-dependent
α-MSH-mediated increases in Km values for the ATR S435
peptide (Figure 3c and Supplementary Table 2 online), but not
for the mutant A435 peptide (Figure 3d and Supplementary
Table 2 online). Taken together, these data strongly suggest
that ATR-pS435 is a PKA-mediated biochemical event and is a
functional biomarker for MC1R functionality.
Agouti stimulating protein and β-defensin 3 inhibit
MSH-induced ATR phosphorylation at S435
Next, we determined the impact of physiological MC1R
antagonists on PKA-mediated ATR phosphorylation by mea-
suring ATR-pS435 levels following α-MSH stimulation in the
presence of various concentrations of either ASIP or HBD3.
α-MSH promoted robust accumulation of ATR-pS435 in
MC1R-WT PHM (Figure 4a and c); addition of increasing
doses of either ASIP or HBD3 inhibited α-MSH-dependent
ATR-pS435 generation as manifested by rightward shifts of
EC50 values (Figure 4a and c) concomitantly with diminution
of PKA activity as determined by CREBtide phosphorylation
(Supplementary Figure 6 online). Furthermore, a dose-
dependent inhibition of ATR-pS435 was observed following
either ASIP or HBD3 treatment (Supplementary Figure 7
online). Of note, by comparing EC50 values between antago-
nists (Figure 4a and c), we found that ASIP was 15–20 times
more effective than HBD3 at antagonizing α-MSH-mediated
ATR-pS435 generation. Importantly, neither ASIP nor HBD3
impacted forskolin-mediated induction of ATR-pS435 (Figure
4b and d), suggesting that ASIP and HBD3 antagonize α-MSH–
MC1R interactions rather than by inhibiting downstream cAMP
responses.
Next, we evaluated the impact of other melanocyte growth
factors on PKA-mediated ATR phosphorylation (Figure 4e).
While α-MSH and ACTH each induced ATR-pS435, neither
endothelin-1 (ET-1), stem cell factor (kit ligand; SCF) nor
hepatocyte growth factor (HGF) promoted PKA-mediated ATR
phosphorylation. Each growth factor, however, inﬂuenced
known downstream effectors (Figure 4f), conﬁrming their
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Figure 2. MC1R-cAMP signaling enhances the kinetics of ATR-pS435 generation. Cell lysates were extracted from (a) HEK293-MC1R-WT, (b) PHM-MC1R-WT,
(c) SK-MEL2-MC1R-WT, (d) HEK293-MC1R-R160W, (e) HEK293-MC1R-D294H, and (f) A375-MC1R-R151C following treatment with forskolin (10 μM), α-MSH
(100 nM), or vehicle for 30 minutes. ATR-pS435 was measured using the peptide CPKRRRLSSSLNPS (10 μM) as a substrate for 3 minutes (phosphorylation of the
substrate was linear within this period). Kinetic parameters of the phosphorylation reaction were calculated by non-linear regression analysis for the oligopeptide
substrate using anti-ATR-pS435 antibody coupled with ﬂuorescence detection. Mutant MC1R cells were unresponsive to α-MSH and were below the limits of
detection. Linearity between ATR-pS435 and various amounts of whole cell extract were conﬁrmed for all cell types (Supplementary Figure 4 online). ATR, ataxia
telangiectasia and rad3-related; MC1R, melanocortin 1 receptor; MSH, melanocyte-stimulating hormone; PHM, primary human melanocyte.
SG Jarrett et al.
MC1R Regulation of ATR Phosphorylation at S435
3088 Journal of Investigative Dermatology (2015), Volume 135
bioactivity in melanocytes. Taken together, these data suggest
that both ASIP and HBD3 interfere with α-MSH-mediated but
not pharmacologically (forskolin)-induced ATR-pS435 gen-
eration and that melanocyte growth factors that signal in an
MC1R-independent manner do not promote PKA-mediated
ATR phosphorylation.
MC1R agonists and antagonists regulate XPA–DNA interactions
Since phosphorylation of ATR at S435 enhances NER by
recruiting XPA to UV-induced DNA damage (Jarrett et al.,
2014), we wished to determine how physiologic MC1R
ligands impact XPA recruitment to photolesions. To do so, the
ORA (Shen et al., 2014) was adapted to measure XPA-
photodamage interactions using a technique that we have
termed “oligonucleotide retrieval assay-immunoprecipitation”
(ORiP). This assay relies on isolation of nuclear lysates,
introduction of a biotinylated construct harboring a UV-
damaged oligonucleotide, retrieval of the oligonucleotide by
streptavidin and identiﬁcation of bound proteins by western
blot. In this way, levels of oligonucleotide-bound XPA and
ATR-pS435 were measured in nuclear lysates of either PHMs
(Figure 5) or HEK cells expressing either MC1R-WT or MC1R-
R151C (Supplementary Figure 8 online) and pre-treated as
indicated. In each case, we observed no association of either
XPA or ATR-pS435 with the undamaged oligonucleotide but
there was robust binding of XPA or ATR-pS435 with UV-
irradiated oligonucleotide. Low levels of either XPA (Figure 5a
and b) or ATR-pS435 (Figure 5c and d) associated with the
photodamage-containing oligonucleotide in unstimulated
cells. Pre-treatment with α-MSH or forskolin, however,
increased accumulation of both XPA (Figure 5a and b and
Supplementary Figure 8 online) and ATR-pS435 (Figure 5c
and d) roughly 3- to 4-fold above vehicle (P⩽0.05).
Incubation of PHMs with either ASIP or HBD3 reduced
photodamage-associated XPA or ATR-pS435 to vehicle-
treated levels (Figure 5a and d) and each was signiﬁcantly
reduced compared with α-MSH alone (P⩽ 0.05). Immunode-
pleting ATR-pS435 abolished any beneﬁt of α-MSH-MC1R-
cAMP signaling on XPA–DNA interactions (Figure 5e and f),
demonstrating the critical role of PKA-mediated ATR phos-
phorylation for cAMP-enhanced XPA recruitement to photo-
damage. These data suggest that ASIP and HBD3 negatively
impact XPA-photodamage interaction by reducing the efﬁ-
ciency of MC1R-cAMP signaling.
MC1R agonists and antagonists regulate NER activity
As XPA and ATR-pS435 recruitment to UV-damaged DNA is
dependent upon effective MC1R signaling, we reasoned that
MC1R ligands would regulate melanocytic NER. As
described, the ORA measures repair by PCR-based ampliﬁca-
tion of an oligonucleotide construct containing a single
chemically-induced thymine dimer whose ampliﬁcation
depends on repair of the photodamage (Shen et al., 2014).
Using this method, the presence of the cyclopyrimidine
dimers (CPD) was veriﬁed by Southwestern blotting
(Figure 6a); however, we adapted the assay by UV-
irradiating the oligonucleotide substrate to generate both
CPDs and [6-4]-photoproducts ([6-4]-PP) (Figure 6b). α-MSH
pre-treatment enhanced the repair of DNA lesions in either
PHM (Figure 6c–f) or MC1R-transfected HEK293 cells
(Supplementary Figure 9 online) compared with vehicle in a
dose-dependent manner (Supplementary Figure 10 online;
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Figure 3. Dose and time response for protein kinase A (PKA)-mediated
phosphorylation of ATR S435. Recombinant PKA (0, 0.1, 1, and 10 nM) or
recombinant PKA (10 nM) with either H-89 (10 μM) or PKI (1 μM) was incubated
with 10 μM peptide (a) CPKRRRLSSSLNPS or (b) CPKRRRLASSLNPS as
substrates for up to 30minutes. Extent of phosphorylation at Ser435 was
measured by an anti-ATR-pS435 antibody. The kinetic parameters of the
phosphorylation reaction were calculated by non-linear regression analysis
using 10 μM of (c) CPKRRRLSSSLNPS or (d) CPKRRRLASSLNPS as substrates
and an anti-ATR-pS435 antibody coupled with ﬂuorescence detection
3minutes into each reaction (non-saturated conditions). ATR, ataxia
telangiectasia and rad3-related; RFU, relative ﬂuorescence unit.
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P⩽0.05). However, when either ASIP (Figure 6c and d) or
HBD3 (Figure 6e and f) was incubated together with α-MSH,
the repair of UV-induced lesions was signiﬁcantly delayed in
either cell type (ASIP; at 10, 50, and 100 nM; P⩽ 0.05 and
HBD3 at 100 nM; P⩽ 0.05). Indeed, NER activity inversely
correlated with increasing concentrations of either ASIP or
HBD3 (Figure 6g and h).
We further delineated the long-term effect of ASIP and
HBD3 on ATR-pS435 and NER independent of α-MSH
signaling. ASIP treatment reduced both ATR-pS435 levels
and NER activity below basal levels (P⩽ 0.05) whereas HBD3
had no signiﬁcant impact on basal ATR-pS435 levels or NER
activity (Figure 6h), suggesting that ASIP but not HBD3
downregulates basal MC1R signaling. Altogether, these data
indicate that melanocyte NER is regulated by agonists and
antagonists of MC1R and identiﬁes ATR-pS435 as a potential
biomarker for the DNA repair-deﬁcient MC1R phenotype.
DISCUSSION
MC1R, a susceptibility gene for melanoma, encodes a Gs
protein-coupled receptor expressed on the surface of mela-
nocytes. MC1R protects cells from malignant degeneration by
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Figure 4. Antagonism of melanocortin 1 receptor (MC1R) signaling by agouti signaling protein (ASIP) or human β-defensin 3 (HBD3) inhibits ATR-pS435
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directing synthesis of UV-blocking melanin and by promoting
genomic stability through enhanced NER (Hauser et al., 2006;
Wong et al., 2012). Despite the fact that we and others have
found MC1R signaling to enhance melanocytic NER by
optimizing the function of numerous DNA repair factors
(Smith et al., 2008; Jagirdar et al., 2013; Jarrett et al., 2014;
Swope et al., 2014), how cAMP coordinates DNA repair
responses is still incompletely understood. We previously
found that MC1R signaling promoted NER through cAMP-
directed PKA-mediated phosphorylation of ATR on the S435
residue which in turn upregulated ATR’s physical association
with XPA and directed XPA to sites of UV damage to
accelerate repair of photoproducts and protect against
UV-induced mutagenesis (Jarrett et al., 2014). Herein, we
examined the role of MC1R agonists and antagonists in
regulating ATR-pS435 generation, XPA’s interactions with
photodamage and on NER using high throughput assays.
Using these methodologies, we determined that in PHMs with
intact MC1R signaling, the ATR-XPA NER axis is heavily
inﬂuenced by agonists and antagonists of MC1R, implying
that melanocyte genomic stability is directly regulated by
MC1R signaling status and concentrations of MC1R ligands in
the local milieu. Historically, kinase assays have relied on
autoradiographic measurement of 32P-containing phosphate
into protein targets of interest. A ﬂuorescence-based method
was developed for detecting ATR-pS435 in vitro using a
14-mer peptide corresponding to residues 428–441 of ATR
that contains the S435 residue in the context of its native PKA
recognition site and that is speciﬁcally and efﬁciently
recognized by a phospho-speciﬁc (ATR-pS435) when phos-
phorylated by PKA. This assay facilitates the study of MC1R
signaling events that regulate ATR-pS435 and detects
picomolar concentrations of ATR-pS435 generated by MSH
or forskolin, which is similar in sensitivity to radiolabelled
phosphorylation assays (Gopalakrishna et al., 1992). Using
this approach, enzyme kinetic studies revealed higher Vmax
and lower Km values for forskolin-mediated ATR-pS435
compared with α-MSH. Physiologically, these different kinetic
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Figure 5. Melanocortin 1 receptor (MC1R) agonists and antagonists regulate XPA– and ATR-pS435-DNA interactions following UV exposure as determined by
ORiP.Wild-type MC1R PHMs were pre-treated with forskolin (10 μM), α-MSH (100 nM), α-MSH (100 nM)+ASIP (100 nM) or HBD3 (100 nM) 30minutes before UV
exposure. PHMs that were not exposed to UV (−UV) were included to determine basal levels of damage. Nuclear extracts were incubated with a photoproduct
containing 5′-biotinylated duplex DNA fragment that acts as a substrate for NER, as described in the Materials and Methods. The levels of (a and b) XPA, (c and d)
ATR-pS435, (e and f) XPA (following immunodepletion (ID) of ATR-pS435) bound to the DNA fragment were quantiﬁed as described in Materials and Methods
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properties suggest the increased “cAMP load” generated by
forskolin may enhance the capability of PKA to recognize
ATR-S435 and/or impact how strongly PKA binds with the
S435 substrate in agreement with prior reports that modula-
tions in PKA activity treatment alter the afﬁnity of the enzyme
for its substrate (Paulucci-Holthauzen et al., 2006).
ASIP and HBD3 efﬁciently blocked α-MSH-mediated effects
on ATR-S435 phosphorylation but had no impact on forskolin-
directed ATR-S435 phosphorylation. ASIP downregulated
basal levels of ATR-pS435, consistent with it being an MC1R
inverse agonist capable of downregulating ligand-independent
MC1R signaling (Suzuki et al., 1997; Scott et al., 2002;
Sanchez-Mas et al., 2004). HBD3, however, had no
discernable impact on constitutive levels of ATR-pS435,
suggesting that it may function as a neutral MC1R antagonist
instead (Candille et al., 2007; Swope et al., 2012). To elucidate
the functional effect of MC1R ligands on DNA repair, we
adapted the oligonucleotide retrieval assay that quantiﬁes
repair by PCR-based ampliﬁcation (Shen et al., 2014). In this
assay, the presence of photoproduct(s) interferes with Taq
polymerase; therefore, the amount of ampliﬁcation across the
oligonucleotide will be proportional to clearance of
photolesions by NER. We adapted this method by directly
UV-radiating the oligonucleotide instead which resulted in
more photodamage (both CPDs and [6-4]-PP) than could be
generated by chemical synthesis of a single CPD alone. NER
responses were regulated by MC1R status and ligand
interactions, mirroring ATR-pS435 accumulation and XPA-
DNA binding. Thus, α-MSH promoted NER while ASIP and
HBD3 blocked α-MSH-mediated enhancement of repair. ASIP
blunted repair of UV-induced DNA damage to a greater extent
than HBD3, which is explained by the fact that ASIP has a
greater ability to inhibit ATR-pS435 generation than HBD3.
We also determined how MC1R ligands impact the
biochemical association of XPA and ATR-pS435 with UV
photodamage by ORiP, an assay we developed that takes
advantage of the biotinylated and photodamaged oligonu-
cleotide utilized in the ORA to identify proteins associated
with UV photodamage. This assay identiﬁed XPA as a key
downstream target of the α-MSH-MC1R-cAMP axis in
melanocytes, which corroborates our previous studies
(Jarrett et al., 2014) and conﬁrms the suitability of ORiP for
the study of DNA–protein interactions. α-MSH pre-treatment
enhanced accumulation of XPA on the UV-damaged DNA
oligonucleotide whereas ASIP and HBD3 each antagonized
the interaction. Previous studies in other systems have shown
XPA to associate with DNA damage in response to UV
irradiation (Lindsey-Boltz et al., 2014); however, data
presented here link MC1R agonists and antagonists with
efﬁciency of XPA recruitment to damaged DNA. Given the
essential roles of XPA in DNA repair and genome
maintenance (Cimprich and Cortez, 2008; Sirbu and Cortez,
2013), our ﬁndings suggest that ligand-MC1R control of XPA
interactions represents an important mechanism underlying
MC1R regulation of NER in melanocytes. Indeed, MC1R
signaling may be an important event that primes early
recruitment and assembly of XPA and possibly other DNA
repair proteins to sites of UV damage.
Together, these ﬁndings support the hypothesis that
MC1R/cAMP signaling controls melanocytic NER through
downstream PKA-mediated ATR phosphorylation on S435
and recruitment of XPA to photodamage. Our data raise the
possibility that in addition to loss-of-function MC1R poly-
morphisms that interfere with cAMP generation in melano-
cytes, dysregulated expression of ASIP or HBD3 in the skin
may also impair DNA repair responses in melanocytes to
heighten UV mutagenesis and melanoma risk. Intriguingly,
multiple factors in UV-damage responses have been shown to
be regulated by cAMP (Smith et al., 2008; Kadekaro et al.,
2012; Swope et al., 2012, 2014; Wong et al., 2012; Jarrett
et al., 2014) and may therefore be impacted by MC1R
signaling or antagonism. In conclusion, our studies shed light
on NER regulation by MC1R ligands and identify ATR-pS435
as a potential biomarker for the DNA repair-deﬁcient MC1R
phenotype.
MATERIALS AND METHODS
Cell lines, plasmids, recombinant proteins, and UV exposure
Transformed cell lines SK-MEL-2, A375, and HEK293 (ATCC)
and primary melanocytes (Coriell Institute for Medical
Research, Camden, NJ) were cultured in RPMI media con-
taining 10% fetal bovine serum. HEK293 cells were transfected
with MC1R-WT, MC1R-R160W or D294H as described
(Jarrett et al., 2014). Recombinant ACTH (Bio-World, Dublin,
OH), ASIP (R&D Systems, Minneapolis, MN), and HBD3 (R&D
Systems) were used as indicated. UV at a dose of 10 J m−2 was
delivered to cell cultures with lamps emitting in the UVB
range.
Antibodies
The ATR antibodies ATR-pS435 and ATR-S435 were
generated against the peptides CPKRRR(pS or S)SSLNPS
(Amsbio, Cambridge, MA). Commercially available
antibodies used were anti-[6-4]-PP (Cosmo.bio), anti-CPD
(Kamiya Biomedical, Seattle, WA), anti-XPA (Kamiya Biome-
dical), anti-FLAG (Sigma-Aldrich, St. Louis, MO), anti-pp38
(Cell Signaling Technology, Danvers, MA), anti-pcKit
(Cell Signaling Technology), and anti-pCREB (Cell Signaling
Technology).
Chromatin isolation and immunoblotting
Chromatin isolation and immuoblotting was performed as
described (Jarrett et al., 2014).
ATR-pS435 detection
ATR-S435 kinase assays were performed using biotin-
ylated ATR peptide substrates, CPKRRRLSSSLNPS or
CPKRRRLASSLNPS (Genscript, Piscataway, NJ). Reactions
containing peptide substrate (10–100 μM) were performed in
strepavidin-coated 96-well plates by the addition of either
10 nM recombinant catalytic subunit of PKA enzyme (Life
Technologies, Grand Island, NY) or chromatin lysate (500 μg)
in 40mM Tris-HCl (pH 7.5), 10mM MgCl2, 1 mM DTT, 100
μg ml− 1 BSA and10 μM ATP. Kinase reactions were carried
out at 30 °C with gentle agitation and terminated by the
addition of 10 μl of 100mM EDTA at indicated times. PKA
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phosphorylation was measured with either anti-ATR-pS435.
Detection was accomplished using an HRP-conjugated anti-
rabbit secondary antibody (Abcam, Cambridge, MA) for 1
hour followed by the addition of QuantaBLu (Life Technol-
ogies). Measurement of relative ﬂuorescence units was
detected with excitation and emission set at 315 and
400 nm. The kinetic parameters of the phosphorylation
reaction were calculated by non-linear regression analysis
with Prism 5.0 (GraphPad, La Jolla, CA).
ORA and oligonucleotide retrieval-immunoprecipitation
ORA was adapted to contain a UV-exposed DNA fragment
containing [6-4]-PP and CPDs rather than a single CPD as
reported previously (Shen et al., 2014). Synthetic
oligonucleotides (Sigma-Aldrich) were assembled to form a
5′-biotinylated duplex DNA fragment that acts as a substrate
for NER. A 30-nt oligonucleotide, 5′-CTCGTCAGCATCTT
CATCATACAGTCAGTG-3′, was exposed to 1 J m−2 of UVC
and was annealed and ligated with two oligonucleotides as
described (Shen et al., 2014). For ORiP, after indicated
treatments, chromatin fractions were incubated with the
biotinylated oligonucleotide in strepavidin-coated 96 well
plates (Thermo-Fisher Scientiﬁc, Waltham, MA) (0.01 nM per
well) for indicated times at 30 °C. Wells were washed with
40mM Tris-HCl (pH 7.5) containing 0.01% BSA (wash buffer)
followed by ﬁxation in 4% paraformaldehyde. After three
washes, 2 μg of either anti-XPA or anti-ATR-pS435 was added
for 1 hour. Detection was accomplished using an HRP-con-
jugated anti-rabbit secondary antibody (Abcam) for 1 hour
followed by the addition of QuantaBLu (Life Technologies) to
each well for 10minutes at 37 °C. Measurement of relative
ﬂuorescence units was detected with excitation and emission
set at 315 and 400 nm. For ORA, either the construct as
described above or a 30-nt oligonucleotide, 5′-CTCGT
CAGCATCTTCATCATACAGTCAGTG-3′, containing a single
CPD (where CPD is marked in bold) was used as a substrate
for NER (generously provided by Dr S Iwai, Osaka University,
Japan) (Nishiguchi et al., 2008; Shen et al., 2014). After
indicated treatments, nuclear lysates (50 μg) were incubated
with the UV-damaged oligonucleotide for indicated times at
30°C. The oligonucleotides were puriﬁed with DNAeasy
extraction kit (Qiagen, Valencia, CA) and streptavidin beads
(Invitrogen). The presence of UVR-induced DNA polymerase–
blocking lesions was assessed using real-time quantitative
PCR as described (Shen et al., 2014). NER activity was
expressed as percentage repair and calculated from ΔCt
values assigning an oligonucleotide exposed to UVC at time
zero as 100% DNA damage.
Statistical analysis
All statistical assays, Student’s t tests, and one-way ANOVA
were performed with Prism 5.0. Data were considered as
statistically signiﬁcant if P-values were less than 0.05.
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